Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
GSK to Invest $30 Billion in R&D and Manufacturing in the United States
GSK plc has announced plans to invest $30 billion across the United States over the next five years in research and development and supply chain infrastructure The investment aims to strengthen GSKs innovation
Gilead Sciences Breaks Ground on $32 Billion U.S. Manufacturing Facility
Gilead Sciences has begun construction on a new Pharmaceutical Development and Manufacturing Technical Development Center NTDC at its headquarters in Foster City, California The fivestorey, 180,000 square foot facility
Johnson & Johnson Expands Operations with $2 Billion North Carolina Facility
Johnson Johnson has confirmed a $2 billion investment to expand its manufacturing presence in the United States This development is part of a wider strategy to increase advanced medicines production
AbbVie to Invest $195 Million in U.S. API Manufacturing Expansion
AbbVie has announced plans to invest $195 million in its North Chicago facility to increase active pharmaceutical ingredient API production in the United States The investment supports the companys strategy
AstraZeneca Announces $50 Billion Investment in US R&D and Manufacturing Facilities
AstraZeneca has announced a major investment of $50 billion in the United States The investment will strengthen the companys presence in both research and development RD and medicines manufacturing
Piramal Pharma Invests $90 Million to Expand U.S. Manufacturing Facilities
Piramal Pharma Solutions is investing $90 million to expand two US facilities, aimed at boosting manufacturing capacity and improving operational efficiency This move supports the companys integrated antibodydrug conjugate
Hikma Invests $1 Billion to Expand its Manufacturing and R&D Operations
Hikma Pharmaceuticals USA has unveiled a strategic plan to invest $1 billion by the year 2030 to expand its manufacturing and research capabilities within the United States This major investment is designed to bolster
Orano Med invests $5 Million to Expand R&D Centre in Texas
Orano Med, a branch of the Orano Group focused on radioligand cancer therapies, has revealed plans to expand its primary RD facility in Plano, Texas, backed by an investment exceeding $5 million
UCB invests $5 billion to Establish New Biologics Manufacturing Facility in the United States
Global biopharmaceutical company UCB has announced plans to build a new advanced biologics manufacturing facility in the United States This strategic investment aims to support the companys expanding presence
Roche and Genentech invest $700+ million in new North Carolina manufacturing facility
Genentech, a subsidiary of the Roche Group, has revealed plans to invest more than $700 million in constructing a new, cuttingedge drug manufacturing facility in Holly Springs, North Carolina
